Ftse Mib
34.262,61
0,22%
DAX
19.966,14
0,29%
S&P 500
5.906,71
0,43%
NASDAQ
19.387,10
0,40%
Bitcoin
96.380,21
2,11%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aclaris Therapeutics Inc (ACRS) Aclaris Therapeutics Inc (ACRS) Notizie

Aclaris Therapeutics Inc

ACRS
2,55
0,07 (2,82%)
Ultimo aggiornamento: 16:35:59
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/1/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
31/12/202422:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/12/202422:31EDGAR2Form S-3 - Registration statement under Securities Act of..
12/12/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202422:30GLOBEAclaris Therapeutics Announces Inducement Grants Under..
03/12/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202422:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/11/202422:30GLOBEAclaris Therapeutics to Participate in the Piper Sandler..
25/11/202417:02EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
22/11/202422:00EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
21/11/202422:51EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
20/11/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202422:05APSThis Healthcare Stock Soared Following Exclusive License..
18/11/202422:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/11/202414:50PRNUSBiosion Announces Exclusive, Global License Agreement with..
18/11/202414:15EDGAR2Form 8-K - Current report
18/11/202414:10GLOBEAclaris Therapeutics Announces $80 Million Private Placement
18/11/202414:10GLOBEAclaris Therapeutics Announces Exclusive, Global License..
06/11/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202413:21EDGAR2Form 8-K - Current report
06/11/202413:00GLOBEAclaris Therapeutics Reports Third Quarter 2024 Financial..
05/11/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/9/202413:00GLOBEAclaris Therapeutics Announces First Patient Dosed in Phase..
10/9/202413:00GLOBEAclaris Therapeutics to Participate in the 2024 Cantor..
05/9/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202413:15EDGAR2Form 8-K - Current report
07/8/202413:00GLOBEAclaris Therapeutics Reports Second Quarter 2024 Financial..
05/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202422:30EDGAR2Form 8-K - Current report
16/7/202422:01GLOBEAclaris Therapeutics Announces Sale of OLUMIANT® Royalties..
10/6/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:15EDGAR2Form 8-K - Current report
06/6/202413:00GLOBEAclaris Therapeutics to Participate in the Goldman Sachs..
04/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:15EDGAR2Form 8-K - Current report
07/5/202422:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/5/202422:01GLOBEAclaris Therapeutics Reports First Quarter 2024 Financial..
30/4/202413:00GLOBEAclaris Therapeutics to Announce First Quarter 2024..
23/4/202414:00PRNUSFlare Therapeutics Appoints Douglas Manion, M.D., FRCP (C)..
Apertura: 2,50 Min: 2,50 Max: 2,60
Chiusura: 2,48

La tua Cronologia

NASDAQ
ACRS
Aclaris Therapeutics
COIN
WPLSETH
Wrapped Pulse from PulseChain
BIT
STMMI
ST Microelectronics
COIN
ACTIUST
Actina Coin
LSE
BS59
Sigma Fin.frn09
LSE
ENET
Ethernity Networks
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network